A joint research project could prove to be a game-changer for New Zealand’s cannabis industry.
Rua Bioscience and the University of Waikato have announced a two-year research programme to investigate the application of hyperspectral technology to the cultivation and assessment of medicinal cannabis.
The cannabis testing industry is expected to be worth $2.5bn (USD$1.8 billion) by 2025, mainly due to global demand for medicinal cannabis.
– Read the entire article at New Zealand Herald.
